Health Literacy and Digital Health in Cancer Patients.
LICAPA
2 other identifiers
observational
1,518
1 country
1
Brief Summary
This is a multicentric, prospective, observational, transversal study, aiming to evaluate the health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale in 2 populations:
- Population A: patients age 65 and over treated in an oncology or oncogeriatric outpatient clinic, or seen in an oncology or oncogeriatric consultation.
- Population B: young patients age 18 to 64 treated in an oncology or outpatient clinic, or seen in an oncology consultation. The following questionnaires:
- Approved French version of the FCCHL scale
- Questionnaire on the use of digital tools adapted from the questionnaire on digital tools, will be completed once only. It will be completed by the participant during the oncology or oncogeriatric consultation or outpatient clinic appointment, in self-questionnaire mode or face to face, assisted if necessary by a family member or member of the medical team.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2021
CompletedStudy Start
First participant enrolled
September 27, 2021
CompletedFirst Posted
Study publicly available on registry
October 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2021
CompletedResults Posted
Study results publicly available
April 12, 2024
CompletedJune 12, 2024
October 1, 2023
1 month
September 23, 2021
October 17, 2023
May 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale.
Health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale. The FCCHL questionnaire includes 14 items, divided into 3 sub-scales, reflecting 3 health literacy skills (functional literacy, interactive literacy and critical literacy). The overall score will be calculated by determining the mean score for the 3 sub-scales. A score of ≤ 4 on the FCCHL scale, corresponds to a low level of health literacy. Each item of the FCCHL takes a score of 1 to 5 points. For each patient, a literacy score per sub-scale will be determined by calculating the number of points divided by the number of items on the sub-scale. The score can range from 1 to 5. The overall literacy score will be calculated as the mean of the 3 sub-scales. This score can range from 1 to 5. For functional scale, higher value represent worse outcome and for the other scale, a higher value represent a better outcome.
1 month
Secondary Outcomes (1)
Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools.
1 month
Study Arms (2)
Population A
65 years old and more
Population B
18 to 64 years old
Interventions
* Approved French version of the FCCHL scale * Questionnaire on the use of digital tools adapted from the questionnaire on digital tools
Eligibility Criteria
Patients seen in an oncology, or oncogeriatric consultation or treated in an oncology or geriatric outpatient clinic (not including full hospitalisation lasting ≥ 24h).
You may qualify if:
- Man or woman.
- Age ≥ 18 years.
- Patient treated for cancer.
- Patient who can read and understand French.
- Patient seen in an oncology or oncogeriatric consultation or treated in an outpatient clinic.
- Patient in treatment or about to start treatment that has been offered to them, from the announcement consultation to 2 years after the start of treatment
You may not qualify if:
- Patient hospitalised for longer than 24 hours.
- Patient with know cognitive impairment preventing them from answering the questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pr Elene Paillaud
Paris, France
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Pr Elena Paillaud
- Organization
- Hôpital Européen Georges Pompidou
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2021
First Posted
October 7, 2021
Study Start
September 27, 2021
Primary Completion
November 8, 2021
Study Completion
December 16, 2021
Last Updated
June 12, 2024
Results First Posted
April 12, 2024
Record last verified: 2023-10